The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility. A North Carolina outsourcing facility is pulling 22 vials of ...
Neha Bora and similar Maoists do not accept the Indian Constitution at all. Their objective is to attack constitutional institutions ...
North Korean hackers are using a post-quantum cryptographic mechanism to secure malicious payload delivery in new operations that combine old and new malware.
Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according to the Food and Drug Administration.
At ISC 2016, Edward Ahearne, a Senior Analytical Scientist in AstraZeneca's Early Chemical Development New Modalities group, was interviewed by LCGC International on why his team combined automated ...
AI/ML-based adaptive fraud analytics leads growth as real-time payments, generative-AI-driven fraud, tighter regulation and vendor consolidation reshape the marketDublin, Oct. 21, 2026 (GLOBE NEWSWIRE ...
Ed Ahearne combined automation , machine learning and Bayesian optimization to speed up method development for siRNA medicines. At ISC 2016, Edward Ahearne of AstraZeneca’s Pharmaceutical Sciences - ...
NAB chairman says recovered railway assets are worth over Rs6 trillion, claims Rs9.17 trillion in recoveries during ...
MOSES LAKE — Consultants hired by the city of Moses Lake to come up with some affordable options for dressing up downtown ...
October 13, 2026, was a day with no orders and no rule triggers. All six stocks I held maintained unrealized gains, and today ...